DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Evexia Lifecare Ltd (EVEXIA) share price today?

Evexia Lifecare Ltd (EVEXIA) is trading at ₹1.67 on the BSE, up 1.21% on the day. Source: DocStoX.

What is the PE ratio of Evexia Lifecare Ltd?

Evexia Lifecare Ltd has a price-to-earnings (PE) ratio of 291.0 in the Commodities sector.

What is the market capitalisation of Evexia Lifecare Ltd?

Evexia Lifecare Ltd has a market capitalisation of approximately ₹315 crore.

Evexia Lifecare Ltd

EVEXIA·BSE·Commodities

₹1.67▲ +0.02 (+1.21%)

Commodities · Chemicals & Petrochemicals

A steady, established business

Day₹1.62

₹1.73

52W₹0

₹262%

Open

₹1.68

High

₹1.73

Low

₹1.62

Prev Close

₹1.65

Volume

62.43L

VWAP

₹1.68

Snapshot

Key fundamentals

Market Cap

₹315 Cr

P/E Ratio

291.00Expensive

P/B Ratio

0.58

EPS

₹0.01

Book Value

₹2.87

ROE

1.06%Weak

ROCE

0.00%Weak

Dividend Yield

0.00%

Debt / Equity

0.84Moderate

Face Value

₹1.00

52W High

₹2.42

52W Low

₹0.47

Sector

Commodities

Industry

Chemicals & Petrochemicals

Expensive

None moatVery High uncertainty

Fair value estimate

₹2

▲ 1.3%upside

Trading at ₹2 — 1% below our estimate

BearFair valueBull

₹1₹2₹2

/100

Business quality — Watch the fundamentals

Growth 50Profitability 0Efficiency 0Valuation 29

Plain English

Our view

A steady, established business
Weak returns on equity (1%)

Risks

Weak returns on equity (1%)
Expensive — trades at 291× earnings

How we got there

Fair value methods

Residual income

1% ROE fading to 14% over ~3 yrs, on ₹3 book

₹2

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹1

Analyst target

No analyst coverage

—

Blended fair value₹2

What the numbers say

Investment thesis

Bull case

No standout positives from the current metrics.

Bear case

Weak returns on equity (1%)
Expensive — trades at 291× earnings

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

291.0Expensive

Below 15× is value territory; above 35× prices in strong growth

ROE

1.1%Weak

Above 15% is considered healthy for Indian equities

ROCE

0.0%Weak

Above 18% means capital is working hard

Debt/Eq

0.84Moderate

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹315 Cr

P/B

0.58

EPS

₹0.01

Div Yield

—

What changed

Recent changes

Foreign investors-0.3% stake last quarter
Promoters-0.13% stake last quarter

What matters

News impact

Overview

Valuation

Expensive

P/E 291.0×

Growth

Strong

+25% rev CAGR

Profitability

Modest

1.1% ROE

Financial health

Comfortable

D/E 0.84

Momentum

N/A

No technicals

Today

Trading activity

Delivery %—

Turnover₹104.91L Cr

Trades570

VWAP₹1.68

Face value₹1.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+25.3%

+7.7%

10Y

-4.7%

Profit

+17.4%

+10.1%

10Y

+4.9%

EPS

-20.6%

+0.0%

10Y

+0.0%

Profile

Pros

Stock is trading at 0.55 times its book value
Company is expected to give good quarter

Watch-outs

Cons

Though the company is reporting repeated profits, it is not paying out dividend
Promoter holding is low: 3.36%
Promoter holding has decreased over last 3 years: -6.50%

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Promoters trimmed their stake by 0.13 pts; foreign investors sold 0.35 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

Promoter

Promoters

3.4%-0.13

Public

40.8%+3.45

FII / FPI

0.1%-0.35

DII

0.1%0.00

Others

55.6%

Total shareholders

1,44,416-2,082 QoQ

Quarterly trend

Ownership over time

Q4 FY26

Promoter3.36%

FII0.12%

DII0.10%

Public40.81%

Others55.61%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Incorporated in 1990, Evexia Lifecare Ltd does trading of Chemicals, Agriculture Produce and other Consumer Goods[1]